CA2207775A1 - Procede favorisant le don de sang autologue et permettant le traitement de la dette d'oxygene - Google Patents
Procede favorisant le don de sang autologue et permettant le traitement de la dette d'oxygeneInfo
- Publication number
- CA2207775A1 CA2207775A1 CA002207775A CA2207775A CA2207775A1 CA 2207775 A1 CA2207775 A1 CA 2207775A1 CA 002207775 A CA002207775 A CA 002207775A CA 2207775 A CA2207775 A CA 2207775A CA 2207775 A1 CA2207775 A1 CA 2207775A1
- Authority
- CA
- Canada
- Prior art keywords
- blood
- oxygen
- hemoglobin
- rhbl
- cell
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/02—Blood transfusion apparatus
Landscapes
- Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Engineering & Computer Science (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Materials For Medical Uses (AREA)
Abstract
La présente invention concerne un procédé favorisant le don de sang autologue. Ce procédé consiste à administrer, après prélèvement d'une partie du sang d'un patient, une dose d'hémoglobine acellulaire accroissant l'apport en oxygène. L'invention concerne également un procédé de traitement de la dette d'oxygène par administration d'une dose d'hémoglobine acellulaire accroissant l'apport en oxygène.
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US37218695A | 1995-01-13 | 1995-01-13 | |
US47752995A | 1995-06-07 | 1995-06-07 | |
US47752895A | 1995-06-07 | 1995-06-07 | |
US08/477,528 | 1995-06-07 | ||
US08/372,186 | 1995-06-07 | ||
US08/477,529 | 1995-06-07 |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2207775A1 true CA2207775A1 (fr) | 1996-09-19 |
Family
ID=27409067
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002207775A Abandoned CA2207775A1 (fr) | 1995-01-13 | 1996-01-16 | Procede favorisant le don de sang autologue et permettant le traitement de la dette d'oxygene |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP0802805A1 (fr) |
JP (1) | JPH11501829A (fr) |
AU (1) | AU4746596A (fr) |
CA (1) | CA2207775A1 (fr) |
WO (1) | WO1996028197A1 (fr) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN117695460A (zh) * | 2023-12-29 | 2024-03-15 | 中山大学附属第一医院 | 一种多功能血液回收装置及其使用方法 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4416280A (en) * | 1980-04-07 | 1983-11-22 | Minnesota Mining And Manufacturing Company | Cardioplegia delivery system |
GB8711614D0 (en) * | 1987-05-16 | 1987-06-24 | Medical Res Council | Proteins |
US4883455A (en) * | 1988-09-13 | 1989-11-28 | Minnesota Mining And Manufacturing Company | Cardioplegia administration set |
US5344393A (en) * | 1992-02-28 | 1994-09-06 | Alliance Pharmaceutical Corp. | Use of synthetic oxygen carriers to facilitate oxygen delivery |
-
1996
- 1996-01-16 WO PCT/US1996/000113 patent/WO1996028197A1/fr not_active Application Discontinuation
- 1996-01-16 CA CA002207775A patent/CA2207775A1/fr not_active Abandoned
- 1996-01-16 JP JP8525893A patent/JPH11501829A/ja active Pending
- 1996-01-16 AU AU47465/96A patent/AU4746596A/en not_active Abandoned
- 1996-01-16 EP EP96903354A patent/EP0802805A1/fr not_active Withdrawn
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN117695460A (zh) * | 2023-12-29 | 2024-03-15 | 中山大学附属第一医院 | 一种多功能血液回收装置及其使用方法 |
CN117695460B (zh) * | 2023-12-29 | 2024-05-10 | 中山大学附属第一医院 | 一种多功能血液回收装置及其使用方法 |
Also Published As
Publication number | Publication date |
---|---|
WO1996028197A1 (fr) | 1996-09-19 |
JPH11501829A (ja) | 1999-02-16 |
AU4746596A (en) | 1996-10-02 |
EP0802805A1 (fr) | 1997-10-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Vlahakes et al. | Hemodynamic effects and oxygen transport properties of a new blood substitute in a model of massive blood replacement | |
US6007774A (en) | Method for the treatment of organ ischemia or infarct comprising hemodilution | |
Dunn et al. | Hemodynamic, metabolic, and hematologic effects of pulsatile cardiopulmonary bypass | |
US5451205A (en) | Facilitated oxygen delivery in conjunction with hemodilution | |
Keipert | Use of Oxygent™, a perfluorochemical-based oxygen carrier, as an alternative to intraoperative blood transfusion | |
US5082831A (en) | Total body washout solution and method of use | |
Goodin et al. | A perfluorochemical emulsion for prehospital resuscitation of experimental hemorrhagic shock: a prospective, randomized, controlled study | |
Niinikoski et al. | Oxygen transport to tissue under normovolemic moderate and extreme hemodilution during coronary bypass operation | |
Engelman et al. | High-volume crystalloid cardioplegia: an improved method of myocardial preservation | |
Takahashi | Characterization of neo red cells (NRCs), their function and safety in vivo tests | |
Dunlap et al. | Resuscitation with diaspirin crosslinked hemoglobin in a pig model of hemorrhagic shock | |
Menasche et al. | Limitation of vasodilation associated with warm heart operation by a “mini-cardioplegia” delivery technique | |
Gould et al. | Hypovolemic shock | |
Mitsuno et al. | Recent studies on perfluorochemical (PFC) emulsion as an oxygen carrier in Japan | |
CA2207775A1 (fr) | Procede favorisant le don de sang autologue et permettant le traitement de la dette d'oxygene | |
Couch et al. | Autotransfusion in three variations | |
Agishi et al. | (Pyridoxalated Hemoglobin)-(Polyoxyethylene) Conjugate Solution as Blood Substitute for Normothermic Whole Body Rinse-Out | |
Watzek et al. | Experience with “isovolaemic” haemodilution in extensive surgery for oro-facial tumours | |
CA2085475A1 (fr) | Solutions hyperosmotiques pour reequilibration de la natremie | |
Parrish et al. | Prebypass pheresis and red blood cell exchange in a patient with homozygous SS sickle cell disease undergoing cardiopulmonary bypass: a case report | |
Rawlings et al. | Prolonged perfusion with a membrane oxygenator in awake ponies | |
WO2000013501A9 (fr) | Fluides sanguins artificiels ameliores | |
Ecker et al. | Changes in 2, 3-diphosphoglycerate after cardiopulmonary bypass | |
CA2315877C (fr) | Facilitation de l'oxygenation associee a une hemodilution | |
RU2195169C2 (ru) | Способ восполнения кровопотери |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Dead |